Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bladder cancer

Assessing the conundrum of microscopic haematuria

The compliance of physicians to current guidelines for asymptomatic microhaematuria is limited and the evidence supporting asymptomatic microhaematuria as an effective screening tool for the early detection of bladder cancer is weak. Medical or surgical treatment is indicated in 13–35% of patients with asymptomatic microhaematuria, albeit mostly for benign conditions, which are more commonly the cause. The high prevalence of asymptomatic microhaematuria in the general population means that this condition poses a considerable challenge to the health-care system.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Davis, R. et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J. Urol. 188 (Suppl.), 2473–2481 (2012).

    Article  PubMed Central  Google Scholar 

  2. Schmitz-Drager, B. J. et al. Microhematuria assessment an IBCN consensus — based upon a critical review of current guidelines. Urol. Oncol. 34, 437–451 (2016).

    Article  PubMed Central  Google Scholar 

  3. Burger, M. et al. Photodynamic diagnosis of non-muscle invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur. Urol. 64, 846–854 (2013).

    Article  PubMed Central  Google Scholar 

  4. Richards, K. A., Ham, S., Cohn, J. A. & Steinberg, G. D. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: implications for sex disparities. Int. J. Urol. 23, 42–47 (2016).

    Article  PubMed Central  Google Scholar 

  5. Cohn, J. A. et al. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120, 555–561 (2014).

    Article  PubMed Central  Google Scholar 

  6. Brehmer, M. Imaging for microscopic hematuria. Curr. Opin. Urol. 12, 155–159 (2002).

    Article  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary D. Steinberg.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steinberg, G. Assessing the conundrum of microscopic haematuria. Nat Rev Urol 13, 700–701 (2016). https://doi.org/10.1038/nrurol.2016.229

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.229

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research